Lung Neoplasms (Lung Cancer) Summary

Networked: 33786 relevant articles (1391 outcomes, 6635 trials/studies) for this Disease

Key Drugs and Agents for Lung Neoplasms

1. Cisplatin (Platino) : 78 outcomes 253 studies in 957 results : FDA 6 Generic
   
2. Epidermal Growth Factor Receptor (EGF Receptor) : 68 outcomes 94 studies in 983 results : IBA
   
3. gefitinib (Iressa) : 64 outcomes 105 studies in 526 results : FDA 1
   
4. Protein-Tyrosine Kinases (Tyrosine Kinase) : 50 outcomes 60 studies in 609 results : IBA
   
5. Paclitaxel (Taxol) : 39 outcomes 103 studies in 389 results : FDA 13 Generic
   
6. erlotinib (CP 358,774) : 33 outcomes 62 studies in 349 results : FDA 1
   
7. Biological Markers (Surrogate Marker) : 28 outcomes 183 studies in 939 results : IBA
   
8. docetaxel (Taxotere) : 27 outcomes 63 studies in 208 results : FDA 3
   
9. Carboplatin (JM8) : 23 outcomes 85 studies in 231 results : FDA 29 Generic
   
10. Platinum : 23 outcomes 68 studies in 251 results : IBA
    

Diseases Related to Lung Neoplasms

1. Neoplasms (Cancer)
2. Neoplasm Metastasis (Metastasis)
3. Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
4. Breast Neoplasms (Breast Cancer)
5. Carcinoma (Carcinomatosis)

Key Therapies for Lung Neoplasms

1. Drug Therapy (Chemotherapy) : 231 outcomes 595 studies in 2777 results
   
2. Radiotherapy : 85 outcomes 254 studies in 1664 results
   
3. Heterologous Transplantation (Xenotransplantation) : 53 outcomes 67 studies in 557 results
   
4. Immunotherapy : 28 outcomes 84 studies in 345 results
   
5. Chemoprevention : 24 outcomes 143 studies in 360 results